Cited by 337Probiotics and Fermented FoodsInflammatory Bowel DiseaseGut microbiota and health

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives

Open access
Roy, Supriya, Dhaneshwar, Suneela·2023·World Journal of Gastroenterology

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of gastrointestinal (GI) tract with dysregulated mucosal immune functions and disturbed commensal ecosystem of the intestinal lumen.IBD is categorized into two major subsets: Crohn's disease (CD) and ulcerative colitis (UC).Though advent of biologics has shifted the treatment with relatively longer remission compared to small molecule pharmaceuticals, patients still suffer from long-term complications.Since gutmicrobiome is now accepted as another human organ holding potential for long-lasting human health, probiotics, and its engineering hold great promises to treat several previously untreatable chronic inflammatory conditions including IBD.Several emerging biological engineering tools have unlimited potential to manipulate probiotic bacterial system.These can produce useful therapeutic biologics with a goal to either ameliorate and/or treat previously untreatable chronic inflammatory conditions.As gut-microbiome is diverse and vary in different ethnic, geographic, and cultural human population, it will be important to develop vision for personalized probiotic treatment and develop the technology thereof to make personalized probiotic options a reality.The aim of this review paper is to present an overview of the current knowledge on both pharmacological and nonpharmacological IBD treatment modalities with a special emphasis on probiotic strains that are developed through the probiotic engineering.These engineered probiotics contain the most anti-inflammatory cytokines found within the human immune response and are currently being used to treat the intestinal inflammation in IBD for the IBD treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v29.i14.2078

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [46]Bamola VD Dubey D Samanta P Kedia S Madempudi RS Neelamraju J Ahuja V Chaudhry R Effect of Bacillus coagulans Unique IS-2 in Inflammatory Bowel Disease (IBD): A Randomized Controlled Trial. 2021 Preprint. Available from: medRxiv:2021.07.18.21260556

Cited by

Sorted by citations

Authors
Roy, S., & Dhaneshwar, S.
Affiliations
  • Amity University (IN)
  • Amity University Mumbai (IN)
Venue
World Journal of Gastroenterology
Published
2023-04-14
Volume
29
Issue
14
Pages
2078-2100
ISSN
1007-9327 (ISSN-L)
OpenAlex
W4365152756
Cited by
334
References
100
Citations by year
2026: 91 · 2025: 125 · 2024: 95 · 2023: 23
FWCI
7.72
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Gastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
inflammatory bowel disease, Crohn's disease, ulcerative colitis, probiotics, prebiotics, synbiotics, gut microbiota, probiotic engineering, engineered probiotics, anti-inflammatory cytokines, intestinal inflammation, mucosal immunity
MeSH terms
Humans, Inflammation, Inflammatory Bowel Diseases, Probiotics, Prebiotics, Synbiotics, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review